Everything you need to win Stanford Medicine Laboratory for Cell and Gene Medicine — in one platform.
Who to reach, what to say, and why now on Stanford Medicine Laboratory for Cell and Gene Medicine — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Stanford Medicine Laboratory for Cell and Gene Medicine — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
The decision-maker’s email and mobile — dial in-browser.
Stanford Medicine Laboratory for Cell and Gene Medicine Awarded Inaugural G-Rex Grant in Collaboration with ScaleReady, Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady
Aug 27, 2024•almost 2 years ago
Contract Type
partnership
St. PaulManufacturingBiotechnologyHealth Care
Description
Stanford Medicine Laboratory for Cell and Gene Medicine has been awarded the inaugural G-Rex Grant worth $300,000 in collaboration with ScaleReady, Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady. The grant will enable the expeditious development of Stanford Medicine's LCGM's G-Rex platform for CAR-T cell therapy manufacturing and support a greater number of clinical trials.
Company Information
Company
Stanford Medicine Laboratory for Cell and Gene Medicine
Location
St. Paul, Minnesota, United States
About
Stanford Medicine Laboratory for Cell and Gene Medicine (LCGM) is a leading research institution focusing on the development and manufacturing services for cell and gene therapies.
Predictive Intelligence
Strategic
ML-powered predictions for Stanford Medicine Laboratory for Cell and Gene Medicine's next move
St. PaulManufacturingBiotechnologyHealth Care